P-99 PREVALENCE OF SARCOPENIA IN PATIENTS WITH LIVER CIRRHOSIS. A CROSS-SECTIONAL STUDY AT TEODORO MALDONADO CARBO HOSPITAL

Introduction

Sarcopenia (S) in liver cirrhosis (LC) is associated with an increased in morbi-mortality. Therefore, identifying it is an important prognostic parameter in the diagnosis of this groups of patients.

Objective

Determine the prevalence of Sarcopenia in patients with Liver Cirrhosis.

Method

Observational, analytical, cross-sectional study.

HTMC AS400 system was performed in a population of 300 patients with LC who attended in the period 2015-2018. One hundred of them met inclusion criteria: (1) LC of any etiology; (2) ≥18 years and (3) with an Abdominal CT Scan with transverse section at L3 level. Patients with LC who had other associated serious and/or malignant pathologies were excluded.

To evaluate Sarcopenia, we used the program NIH IMAGEJ that determines the muscle mass index in Hounsfield Units, with cut-off point for: Men ≤ 52.4 cm²/m² and Women ≤38.5 cm²/m². Results were evaluated using chi-square and Mann-Whitney U (v.3.6.0 Foundation for Statistical Computing; Vienna, Austria).

Results

Baseline characteristics.

Conclusion

Sarcopenia was present in 66% of patients with Liver Cirrhosis. It was significantly predominant in the male gender, but there were no statistical differences with respect to etiology.